Biocon Hits 100M Insulin Cartridges in Malaysia

  Published 11 months ago

Biocon's Malaysian subsidiary surpassed 100 million insulin cartridges for Malaysia's MoH, serving 345,000 patients since 2016.

  • Public-private partnership drives innovation and local talent development in Malaysia's biotech ecosystem.
  • Over 345,000 patients benefited from affordable insulin access since the 2016 market entry.
  • Achievement advances Malaysia's insulin self-sufficiency and diabetes care transformation.

You might like these

India Markets Dip on Trade & Geopolitical Tensions

RBI August: Trade, Growth, Inflation

Brigade Hotel IPO Fully Subscribed

Trent Shares Drop 7% Amid Growth Concerns

MobiKwik Stock Surges 15% on Supply Relief

MSMEs: Engine of India's Future Growth

Leadership Shift at Can Fin Homes: CFO Change & New Appointments

News that matters the most ⚡